Flavonoid and lignan intake and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort

International Journal of Cancer

Volumn 139, Issue 7, 2016, Pages 1480-1492

  Molina Montes, Esther ^a,b   Sánchez, María José ^a,b   Zamora Ros, Raul ^c   Bueno de Mesquita, H Bas ^d,e,f,g   Wark, Petra A ^f   Obon Santacana, Mireia ^h   Kühn, Tilman ⁱ   Katzke, Verena ⁱ   Travis, Ruth C ^j   Ye, Weimin ^k,l   Sund, Malin ^k,l   Naccarati, Alessio ^m   Mattiello, Amalia ⁿ   Krogh, Vittorio ^o   Martorana, Caterina ^p   Masala, Giovanna ^q   Amiano, Pilar ^b,r   Huerta, José María ^b,s   Barricarte, Aurelio ^b,t   Quirós, José Ramón ^u   Weiderpass, Elisabete ^k,v,w,x   Angell Åsli, Lene ^v   Skeie, Guri ^v   Ericson, Ulrika ^y   Sonestedt, Emily ^y   Peeters, Petra H ^e,f   Romieu, Isabelle ^c   Scalbert, Augustin ^c   Overvad, Kim ^z   Clemens, Matthias ^aa   Boeing, Heiner ^aa   Trichopoulou, Antonia ^ab,ac   Peppa, Eleni ^ab   Vidalis, Pavlos ^ab   Khaw, Kay Tee ^ad   Wareham, Nick ^ae   Olsen, Anja ^af   Tjønneland, Anne ^af   Boutroun Rualt, Marie Christine ^ag   Clavel Chapelon, Françoise ^ag   Cross, Amanda J ^f   Lu, Yunxia ^f   Riboli, Elio ^f   Duell, Eric J ^h   more..

^a UNIVERSITY OF GRANADA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g UNIVERSITY OF MALAYA   (Malaysia)

^h CATALAN INSTITUTE OF ONCOLOGY   (Spain)

ⁱ GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^j UNIVERSITY OF OXFORD   (United Kingdom)

^k KAROLINSKA INSTITUTE   (Sweden)

^l UMEÅ UNIVERSITY   (Sweden)

^m Human Genetics Foundation   (Italy)

ⁿ UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^o NATIONAL CANCER INSTITUTE   (Italy)

^p Cancer Registry ASP 7   (Italy)

^q CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^r BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^s DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^t INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^u Public Health Directorate   (Spain)

^v UNIVERSITY OF TROMSØ   (Norway)

^w CANCER REGISTRY OF NORWAY   (Norway)

^x FOLKHÄLSAN RESEARCH CENTER   (Finland)

^y LUND UNIVERSITY   (Sweden)

^z AARHUS UNIVERSITY   (Denmark)

^aa GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^ab HELLENIC HEALTH FOUNDATION   (Greece)

^ac UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^ad UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ae MEDICAL RESEARCH COUNCIL   (United Kingdom)

^af DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^ag CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

more..

Author keywords

cohort; diet; flavonoids; lignans; pancreatic cancer

Indexed keywords

ANTHOCYANIDIN DERIVATIVE; FLAVAN 3 OL MONOMER; FLAVANOL; FLAVANONE DERIVATIVE; FLAVONOID; LIGNAN; THEAFLAVIN; UNCLASSIFIED DRUG;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CALORIC INTAKE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIETARY INTAKE; DIETARY QUESTIONNAIRE; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PANCREAS CANCER; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK REDUCTION; SEX DIFFERENCE; SMOKING; WAIST CIRCUMFERENCE;

EID: 84978296091     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30190     Document Type: Article

References (45)

1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2012;49:1374–403.
2. Maisonneuve P, Lowenfels AB. Risk factors for pancreatic cancer: a summary review of meta-analytical studies. Int J Epidemiol 2015;44:186–98.
3. AICR/WCRF. Continuous Update Project. Pancreatic Cancer (2012). Available at: http://www.wcrf.org/cancer_research/cup/key_findings/pancreatic_cancer.php. Accessed September 23, 2014.
4. Johnson J, Gonzalez de Mejia E. Dietary factors and pancreatic cancer: the role of food bioactive compounds. Mol Nutr Food Res 2011;55:58–73.
5. Ross J, Kasum C. Dietary flavonoids: bioavailability, metabolic effects and safety. Annu Rev Nutr 2002;22:19–34.
6. Ramos S. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol Nutr Food Res 2008;52:507–26.
7. Woo HD, Kim J. Dietary flavonoid intake and smoking-related cancer risk: a meta-analysis. PLoS One 2013;8:e75604.
8. Zamora-Ros R, Sacerdote C, Ricceri F, et al. Flavonoid and lignan intake in relation to bladder cancer risk in the European prospective investigation into cancer and nutrition (EPIC) study. Br J Cancer 2014;111:1870–80.
9. Wang L, Lee IM, Zhang SM, et al. Dietary intake of selected flavonols, flavones and flavonoid rick foods and risk of cancer in middle aged and older women. Am J Clin Nutr 2009;89:905–12.
10. Arts ICW, Hollman PC, Bueno de Mesquita HB, et al. Dietary catechins and epithelial cancer incidence: the Zutphen elderly study. Int J Cancer 2001;92:298–302.
11. Miller PE, Snyder DC. Phytochemicals and cancer risk: a review of the epidemiological evidence. Nutr Clin Pract 2012;27:599–612.
12. Arts ICW, Jacobs DR, Gross M, et al. Dietary catechins and cancer incidence among postmenopausal women: the Iowa Womeńs Health Study. Cancer Causes Control 2002;13:373–82.
13. Arem H, Bobe G, Sampson J, et al. Flavonoid intake and risk of pancreatic cancer in the national institutes of health-AARP diet and health study cohort. Br J Cancer 2013;108:1168–72.
14. Bobe G, Weinstein SJ, Albanes D, et al. Flavonoid intake and risk of pancreatic cancer in male smokers (Finland). Cancer Epidemiol Biomarkers Prev 2008;17:553–62.
15. Cutler GJ, Nettleton Ja Ross JA, et al. Dietary flavonoid intake and risk of cancer in postmenopausal women: the Iowa Womeńs Health study. Int J Cancer 2008;123:664–71.
16. Knekt P, Jarvinen R, Seppänen R, et al. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol 1997;146:223–30.
17. Nöthlings U, Murphy SP, Wilkens LR, et al. Flavonols and pancreatic cancer risk: the multiethnic cohort study. Am J Epidemiol 2007;166:924–31.
18. Rossi M, Lugo A, Lagiou P, et al. Proanthocyanidins and other flavonoids in relation to pancreatic cancer: a case-control study in Italy. Ann Oncol 2012;23:1488–93.
19. Nöthlings U, Murphy SP, Wilkens LR, et al. A food pattern that is predictive of flavonol intake and risk of pancreatic cancer. Am J Clin Nutr 2008;88:1653–62.
20. Koushik A, Spiegelman D, Albanes D, et al. Intake of fruits and vegetables and risk of pancreatic cancer in a pooled analysis of 14 cohort studies. Am J Epidemiol 2012;176:373–86.
21. Zamora-Ros R, Forouhi NG, Sharp SJ, et al. The association between dietary flavonoid and lignan intakes and incident type 2 diabetes in European populations: the EPIC-InterAct study. Diabetes Care 2013;36:3961–70.
22. Liu YJ, Zhan J, Liu XL, et al. Dietary flavonoids intake and risk of type 2 diabetes: a meta-analysis of prospective cohort studies. Clin Nutr 2004;33:59–63.
23. Zamora-Ros R, Knaze V, Luján-Barroso L, et al. Differences in dietary intakes, food sources, and determinants of total flavonoids between Mediterranean and non-Mediterranean countries participating in the European prospective investigation into cancer and nutrition (EPIC) study. Br J Nutr 2013;109:1498–507.
24. Zamora-Ros R, Knaze V, Rothwell JA, et al. Dietary polyphenol intake in Europe: the European prospective investigation into cancer and nutrition (EPIC) study. Eur J Nutr 2016;55:1359–75.
25. Riboli E, Kaaks R. The EPIC Project: rationale and study design. European prospective investigation into cancer and nutrition. Int J Epidemiol 1997;26:S6–S14.
26. Riboli E, Hunt KJ, Slimani N, et al. European prospective investigation into cancer and nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113–24.
27. Slimani N, Deharveng G, Unwin I, et al. The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study. Eur J Clin Nutr 2007;61:1037–56.
28. U.S. Department of Agriculture: USDA database for the proanthocyanidin content of selected foods (2004), USDA database for the flavonoid content of selected foods (2007), USDA database for the isoflavone content of selected foods (2008). Beltsville, MD: USDA.
29. Neveu V, Perez-Jimenez J, Vos F, et al. Phenol-Explorer: an online comprehensive database on polyphenol contents in foods. Database (Oxford) 2010;bap024.
30. Ward HA, Kuhnle GG, Mulligan AA, et al. Breast, colorectal, and prostate cancer risk in the European prospective investigation into cancer and nutrition-Norfolk in relation to phytoestrogen intake derived from an improved database. Am J Clin Nutr 2010;91:440–8.
31. Crozier A, Lean MEJ, McDonald MS, et al. Quantitative analysis of the flavonoid content of commercial tomatoes, onions, lettuces, and celery. J Agric Food Chem 1997;45:590–95.
32. Nöthlings U, Boeing H, Maskarinec G, et al. Food intake of individuals with and without diabetes across different countries and ethnic groups. Eur J Clin Nutr 2011;65:635–41.
33. Haftenberger M, Lahmann PH, Panico S, et al. Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European prospective investigation into cancer and nutrition (EPIC). Public Health Nutr 2002;5:1147–62.
34. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 1982;69:239–41.
35. Heinzl H, Kaider A. Gaining more flexibility in cox proportional hazards regression models with cubic spline functions. Comput Methods Programs Biomed 1997;54:201–8.
36. WHO. Obesity: preventing and managing the global epidemic. Technical Report Series 894. Geneva: WHO, 2002.
37. NCEP. Third report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Circulation 2002;106:3143–421.
38. Zamora-Ros R, Touillaud M, Rothwell JA, et al. Measuring exposure to the polyphenol metabolome in observational epidemiologic studies: current tools and applications and their limits. Am J Clin Nutr 2014;100:11–26.
39. Bhoo-Pathy N, Uiterwaal CS, Dik VK, et al. Intake of coffee, decaffeinated coffee, or tea does not affect risk for pancreatic cancer: results from the European prospective investigation into nutrition and cancer study. Clin Gastroenterol Hepatol 2013;11:1486–92.
40. Genkinger JM, Li R, Spiegelman D, et al. Coffee, tea, and sugar-sweetened carbonated soft drink intake and pancreatic cancer risk: a pooled analysis of 14 cohort studies. Cancer Epidemiol Biomarkers Prev 2012;21:305–18.
41. Sun Q, Wedick NM, Pan A, et al. Gut microbiota metabolites of dietary lignans and risk of type 2 diabetes: a prospective investigation in two cohorts of US women. Diabetes Care 2014;37:1287–95.
42. Babu PV, Liu D, Gilbert ER. Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J Nutr Biochem 2013;24:1777–89.
43. Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2007;132:2208–25.
44. Kaaks R, Riboli E. Validation and calibration of dietary intake measurements in the EPIC project: methodological considerations. Int J Epidemiol 1997;26:S15–S25.
45. Skeie G, Braaten T, Hjartåker A, et al. Use of dietary supplements in the European prospective investigation into cancer and nutrition calibration study. Eur J Clin Nutr 2009;63:S226–S38.